Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study

被引:4868
|
作者
Go, AS
Hylek, EM
Phillips, KA
Chang, YC
Henault, LE
Selby, JV
Singer, DE
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA
[2] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[5] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA
[6] Harvard Univ, Sch Med, Boston, MA USA
来源
关键词
Arrhythmia; Atrial fibrillation; Clinical cardiology (lauer ms; ed); Risk factors;
D O I
10.1001/jama.285.18.2370
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described. Objective To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050, Design, Setting, and Patients Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997, Main Outcome Measures Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050. Results A total of 17974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older. Conclusions Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.
引用
收藏
页码:2370 / 2375
页数:6
相关论文
共 50 条
  • [21] Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation
    Waldo, Albert L.
    CARDIOLOGY CLINICS, 2009, 27 (01) : 125 - +
  • [22] ANTICOAGULATION FOR ATRIAL-FIBRILLATION AND STROKE PREVENTION
    BOYSEN, G
    NEUROEPIDEMIOLOGY, 1993, 12 (05) : 280 - 284
  • [23] Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation
    Piazza, Gregory
    Karipineni, Neelima
    Goldberg, Howard S.
    Jenkins, Kathryn L.
    Goldhaber, Samuel Z.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (20) : 2444 - 2446
  • [24] Anticoagulation: Stroke prevention in patients with atrial fibrillation
    Waldo, Albert L.
    MEDICAL CLINICS OF NORTH AMERICA, 2008, 92 (01) : 143 - +
  • [25] CAROTID STENOSIS IN PATIENTS WITH ATRIAL-FIBRILLATION - PREVALENCE, RISK-FACTORS, AND RELATIONSHIP TO STROKE IN THE STROKE PREVENTION IN ATRIAL-FIBRILLATION STUDY
    KANTER, MC
    TEGELER, CH
    PEARCE, LA
    WEINBERGER, J
    FEINBERG, WM
    ANDERSON, DC
    GOMEZ, CR
    ROTHROCK, JF
    HELGASON, CM
    HART, RG
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (12) : 1372 - 1377
  • [26] Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders
    Luscher, Thomas F.
    EUROPEAN HEART JOURNAL, 2016, 37 (31) : 2443 - 2445
  • [27] Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    Dallalzadeh, Liane O.
    Go, Alan S.
    Chang, Yuchiao
    Borowsky, Leila H.
    Fang, Margaret C.
    Singer, Daniel E.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (07):
  • [28] Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation The KP-RHYTHM Study
    Go, Alan S.
    Reynolds, Kristi
    Yang, Jingrong
    Gupta, Nigel
    Lenane, Judith
    Sung, Sue Hee
    Harrison, Teresa N.
    Liu, Taylor I.
    Solomon, Matthew D.
    JAMA CARDIOLOGY, 2018, 3 (07) : 601 - 608
  • [29] National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
    Dlott, Jeffrey S.
    George, Roberta A.
    Huang, Xiaohua
    Odeh, Mouneer
    Kaufman, Harvey W.
    Ansell, Jack
    Hylek, Elaine M.
    CIRCULATION, 2014, 129 (13) : 1407 - 1414
  • [30] Atrial fibrillation and anticoagulation in patients with permanent pacemakers: Implications for stroke prevention
    Sparks, PB
    Mond, HG
    Kalman, JM
    Jayaprakash, S
    Lewis, MA
    Grigg, LE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (06): : 1258 - 1267